Daniel Moreno-Mitre

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Circulating Tumor

Anti Inflammatory

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Irma Beatriz Mitre-Aguilar, Daniel Moreno-Mitre, Jorge Melendez-Zajgla, Vilma Maldonado-Lagunas, Nadia Judith Jacobo-Herrera, Victoria Ramirez-Gonzalez, Gretel Mendoza-Almanza
The Role of Glucocorticoids in Breast Cancer Therapy. Current oncology (Toronto, Ont.) 30 (1) (2022)
Irma Beatriz Mitre-Aguilar, Daniel Moreno-Mitre, Jorge Melendez-Zajgla, Vilma Maldonado-Lagunas, Nadia Judith Jacobo-Herrera, Victoria Ramirez-Gonzalez, Gretel Mendoza-Almanza
The Role of Glucocorticoids in Breast Cancer Therapy. Current oncology (Toronto, Ont.) 30 (1) (2022)
Irma Beatriz Mitre-Aguilar, Daniel Moreno-Mitre, Jorge Melendez-Zajgla, Vilma Maldonado-Lagunas, Nadia Judith Jacobo-Herrera, Victoria Ramirez-Gonzalez, Gretel Mendoza-Almanza
The Role of Glucocorticoids in Breast Cancer Therapy. Current oncology (Toronto, Ont.) 30 (1) (2022)
Irma Beatriz Mitre-Aguilar, Daniel Moreno-Mitre, Jorge Melendez-Zajgla, Vilma Maldonado-Lagunas, Nadia Judith Jacobo-Herrera, Victoria Ramirez-Gonzalez, Gretel Mendoza-Almanza
The Role of Glucocorticoids in Breast Cancer Therapy. Current oncology (Toronto, Ont.) 30 (1) (2022)
Irma Beatriz Mitre-Aguilar, Daniel Moreno-Mitre, Jorge Melendez-Zajgla, Vilma Maldonado-Lagunas, Nadia Judith Jacobo-Herrera, Victoria Ramirez-Gonzalez, Gretel Mendoza-Almanza
The Role of Glucocorticoids in Breast Cancer Therapy. Current oncology (Toronto, Ont.) 30 (1) (2022)
Irma Beatriz Mitre-Aguilar, Tonatiuh Barrios-Garcia, Victor M Ruiz-Lopez, Alberto J Cabrera-Quintero, Nancy Raquel Mejía-Domínguez, José Luis Ventura-Gallegos, Daniel Moreno-Mitre, Alejandro Aranda-Gutierrez, Minerva Janini Mejía-Rangel, Alma R Escalona-Guzman, Yanin Chavarri Guerra, Alfonso Leon-Del-Rio, Alejandro Zentella-Dehesa
Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells. BMC cancer 19 (1) (2019)